PIDD1 and lung adenocarcinoma: To explore the potential consequences of mutation for PIDDosome function we performed reconstitution assays where PIDD1-deficient U2OS osteosarcoma and A549 lung-adenocarcinoma cells were used to transiently express sgRNA resistant WT, mutant, or truncated PIDD1 proteins.